AMENDMENT NO. 2 TO PRODUCT LICENSE AND ASSIGNMENT AGREEMENTAnd Assignment Agreement • May 8th, 2008 • Cytogen Corp • Pharmaceutical preparations
This Amendment No. 2 to that certain Product License and Assignment Agreement (this “Amendment”) is made and entered into as of February 14, 2008 by and between CYTOGEN CORPORATION, a Delaware corporation having an address at 650 College Road East, Suite 3100, Princeton, New Jersey 08540, United States (“Cytogen”), and INPHARMA AS, a Norwegian company having an address at Pb 2030 (Konnerudgt. 27), 3003 Drammen, Norway (“Inpharma”).
